Impact of stable state symptoms on the future burden of COPD exacerbations
A. Mackay (London, United Kingdom), K. Kostikas (Basel, Switzerland), S. Frent (Timisoara, Romania), P. Pfister (Basel, Switzerland), P. Goyal (Basel, Switzerland), P. Gupta (Hyderabad, India), D. Banerji (East Hanover, United States of America), F. Patalano (Basel, Switzerland), J. Wedzicha (London, United Kingdom)
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Mackay (London, United Kingdom), K. Kostikas (Basel, Switzerland), S. Frent (Timisoara, Romania), P. Pfister (Basel, Switzerland), P. Goyal (Basel, Switzerland), P. Gupta (Hyderabad, India), D. Banerji (East Hanover, United States of America), F. Patalano (Basel, Switzerland), J. Wedzicha (London, United Kingdom). Impact of stable state symptoms on the future burden of COPD exacerbations. 3862
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: